Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 910 (LINC00910) is a long non-coding RNA gene on human chromosome 19, although some sources reference it on chromosome 17, most databases support chromosome 19[3][5]. It does not encode a protein, but like other lincRNAs, it acts as a versatile regulator of gene expression at several molecular levels. LINC00910 can participate in both promoter-like and enhancer-like chromatin interactions, bridging distant DNA loci, altering local chromatin environments, and thereby impacting transcriptional regulation[1][2]. It also influences alternative splicing and gene expression in a cell type-specific manner, likely serving as a scaffold for protein-RNA and nucleic acid interactions. LINC00910 has been found to be differentially expressed in multiple cancers (breast, gastric, lung, osteosarcoma), where it may act as a prognostic marker and may drive tumorigenesis or suppress tumors depending on the context[3][5]. Although its precise molecular mechanisms and broader clinical significance remain under investigation, current evidence points to a key regulatory role in gene networks related to cancer and possibly other diseases, such as polycystic ovary syndrome[1][3][5]. No direct drug interactions, mechanisms of action for drugs, or safety concerns have been reported. LINC00910 is not considered a classical therapeutic target such as a receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 910 (LINC00910).